Twist Bioscience

Speaker

Lin Hui Chang, Ph.D.

Senior Scientist, Illumina Singapore

Dr. Lin Hui Chang is a Senior Scientist at Illumina Singapore. She is part of a group that is tasked to support the protein engineering effort for the company. Prior to Illumina, Lin Hui did her Ph.D. research focusing on protein engineering in ubiquitin signaling under the supervision of Prof. Eric R. Strieter at the University of Massachusetts-Amherst.

Enter Presenter 2 Header

Enter Presenter 2 Name

Enter Presenter 2 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 3 Header

Enter Presenter 3 Name

Enter Presenter 3 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 4 Header

Enter Presenter 4 Name

Enter Presenter 4 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 5 Header

Enter Presenter 5 Name

Enter Presenter 5 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Enter Presenter 6 Header

Enter Presenter 6 Name

Enter Presenter 6 Title

Guannan Wang, PhD, Senior Research Investigator, discusses how they are identifying the driver mutations and clinically actionable biomarkers in all common canine cancers, to arm veterinary clinicians with better prognostic information, target therapeutic options, and markers to predict treatment response, ultimately enabling precision medicine in canine oncology.

Protein Engineering at Illumina

Date & Time

Webinar Description

Enter Details Header

Speaker

Enter Presenter 2 Header

Enter Presenter 3 Header

Enter Presenter 4 Header

Enter Presenter 5 Header

Enter Presenter 6 Header